Clinical Trials Directory

Trials / Completed

CompletedNCT03449550

Validity of a Home Respiratory Polygraphy for the Diagnosis of Obstructive Sleep Apnea in Children (DINISAS)

Validity and Cost-effectiveness Analysis of a Home Respiratory Polygraphy for the Diagnosis of Obstructive Sleep Apnea in Children (DINISAS)

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
320 (actual)
Sponsor
Hospital Universitario Araba · Academic / Other
Sex
All
Age
2 Years – 14 Years
Healthy volunteers
Not accepted

Summary

To assess the diagnostic validity and cost-effectiveness of a home respiratory polygraphy (HRP) performed at home compared with the standard polysomnography (PSG) in children with clinically suspected Obstructive Sleep Apnea (OSA).

Detailed description

AIMS: To assess the diagnostic validity and cost-effectiveness of a home respiratory polygraphy (HRP) performed at home compared with the standard polysomnography (PSG) in children with clinically suspected Obstructive Sleep Apnea (OSA). METHODOLOGY: DESIGN: Randomized, prospective, multicenter, double blind and crossover trial. The study will include 320 children, both sexes, with clinical suspicion of obstructive sleep apnea (OSA). MEASUREMENTS: To all patients with clinical suspected OSA and referred to the sleep units, the following questionnaires and measurements will be performed: a) clinic history; b) Anthropometric variables: weight, height, body mass index, neck circumference and percentile; c) Chervin questionnaire, quality of life and clinical questionnaires and comorbidity; d) PSG in the sleep laboratory; e) HRP at home; f) Quantitative unbiased proteinic urine analysis and g) Cost-effectiveness variables. ANALYSIS: Data from HRP and from full PSG will be compared as follows: 1) Agreement of results according to the different apnea-hypopnea index by using the ROC curves; 2) The concordance of the diagnosis and treatment decisions when using clinical findings and data from PSG or HRP at home, 3) All data will be analyzed independently by participating hospitals according the Cohen Kappa method, 4) A diagnosis paradigm based on proteinic defined variables and 5) A cost-effectiveness analysis of the different diagnostic and therapeutic procedures will be performed.

Conditions

Interventions

TypeNameDescription
OTHERHome Respiratory Polygraphy (HRP)Randomizing to start with home respiratory polygraphy
OTHERStandard Polysomnography (PSG)Randomizing to start with Standard Polysomnography (PSG)
OTHERHome Respiratory Polygraphy (HRP)Randomizing for therapeutic decision taken with home respiratory polygraphy (HRP)
OTHERStandard Polysomnography (PSG)Randomizing for therapeutic decision taken with Standard Polysomnography (PSG)

Timeline

Start date
2015-05-07
Primary completion
2019-04-30
Completion
2020-03-30
First posted
2018-02-28
Last updated
2021-09-09

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT03449550. Inclusion in this directory is not an endorsement.